Home > Healthcare > Medical Devices > Surgical Devices > Pediatric Perfusion Systems Market

Pediatric Perfusion Systems Market Trends

Report ID: GMI7499
Published Date: Nov 2023
Report Format: PDF

Download Free Sample

Pediatric Perfusion Systems Market Trends

The market is influenced by several factors such as increasing advancements in perfusion technology, growing integration of extracorporeal membrane oxygenation (ECMO) technology, adoption of remote monitoring and telehealth solutions, and growing demand for personalized and precision medicine, among others.

Paediatric perfusion devices are being miniaturized, which allows for increased surgical flexibility. Smaller devices are particularly relevant in paediatric procedures, when patients have restricted vascular access or require less invasive procedures.
Moreover, the integration of artificial intelligence (AI) in healthcare and machine learning into paediatric perfusion systems is becoming more prevalent. These technologies are used to analyze enormous data sets, optimise perfusion applications and offer predictive analytics to improve surgical decision-making.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The pediatric perfusion systems industry was valued at USD 318.9 million in 2022 and is estimated to reach over USD 627 million by 2032, attributed to the growing demand for minimally invasive procedures in pediatric cardiac surgery, favorable government initiatives and reimbursement policies.

The pediatric oxygenators segment garnered around USD 99.1 million revenue in 2022. Due to congenital heart defects, neonates and newborns often require cardiac surgeries or procedures, pushing the demand for the specialised oxygenation to meet the physiological requirements of the youngest patients.

North America pediatric perfusion system market accounted for USD 131.6 million in 2022 and is predicted to witness substantial growth as there is a growing focus on pediatric cardiac care in the region, leading to increased investments in specialized services and technologies.

Medtronic, LivaNova PLC, Terumo Cardiovascular Systems Corporation, BL Lifesciences, Cardinal Health, EUROSETS, Getinge AB, Nonin, Edwards Lifesciences Corporation, and Stryker Corporation.